UNSPSC 51342506: Abacavir sulfate

This classification denotes a reverse transcriptase inhibitor, in sulfate form, with the molecular formula 2C14H18N6O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J220T4J9Q2, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, sulfate (salt)(2:1), (1s,4r)- but more generally known as abacavir sulfate, which bears US NIH Compound Identifier 65141. The base compound, abacavir, also appears in succinate form, and is sometimes combined with lamivudine and zidovudine.

UNSPSC 51342506 Abacavir sulfate is a Commodity code for a specific antiretroviral pharmaceutical product. Recent state and local procurement activity under this code does not show direct purchasing of abacavir sulfate; the opportunities tagged to it involve unrelated pharmaceuticals—antibiotic tablets through a state health department warehouse contract and naloxone through a county community health procurement. State and local governments use this code tier to procure individual pharmaceutical SKUs, typically through cooperative purchasing vehicles, piggyback contracts, or emergency preparedness frameworks when they stock HIV treatment medications or support public health programs that include antiretroviral therapy. The issuing bodies are state health departments and county health authorities, often drawing on shared services agreements or established pharmaceutical supplier networks.

The two most recent opportunities tagged to this code are a completed piggyback pharmaceutical warehouse award by the Illinois Department of Public Health (August 28, 2026, through the MMCAP Infuse consortium to Chartwell Rx LLC for $2,999,999.11 total contract value) and a Seminole County, Florida IFB for naloxone and drug deactivation systems (posted June 30, 2026, with a July 26, 2023 response deadline—the latter date appears to be a data error in the source). The Illinois contract supplied doxycycline and ciprofloxacin tablets under a 12-month term with two renewal options; Seminole County sought annual quantities of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and FEMA potential funding. The mismatch between the code's nominal scope and the actual products in these opportunities suggests this code sees little relevant recent activity for abacavir sulfate specifically, or that state and local procurement offices are inconsistently tagging pharmaceutical commodities.